CSE:BIOV - Post Discussion
Post by
1DoxieDollar on Apr 04, 2023 4:10pm
Tweet from BIOV: Expanded / enhanced production capabilities
https://www.polyplus-transfection.com/news/sartorius-acquire-polyplus/
"Congratulations to our biomanufacturing partner Polyplus/BioElpida for its acquisition by Sartorius Stedim Biotech for €2.4 billion. Great news for our #ovariancancer clinical trial! Excellent call today with the expanded team at BioElpida!"
Be the first to comment on this post